A hypoxia-induced vascular endothelial-to-mesenchymal transition in development of radiation-induced pulmonary fibrosis

Clinical Cancer Research

Volumn 21, Issue 16, 2015, Pages 3716-3726

  Choi, Seo Hyun ^a   Hong, Zhen Yu ^b   Nam, Jae Kyung ^a   Lee, Hae June ^a   Jang, Junho ^a   Yoo, Ran Ji ^a   Lee, Yong Jin ^a   Lee, Chang Young ^b   Kim, Kyung Hwan ^b   Park, Seungwoo ^a   Ji, Young Hoon ^a   Lee, Yun Sil ^c   Cho, Jaeho ^b   Lee, Yoon Jin ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; 2-METHOXYESTRADIOL; COLLAGEN; ESTRADIOL; HIF1A PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; ENDOTHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IN VIVO STUDY; INTRACELLULAR SIGNALING; LUNG ALVEOLUS EPITHELIUM CELL; LUNG FIBROSIS; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIATION INDUCED PULMONARY FIBROSIS; RADIATION INJURY; UPREGULATION; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD VESSEL; CELL HYPOXIA; DRUG EFFECTS; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; GENETICS; LUNG; METABOLISM; PATHOLOGY; PULMONARY FIBROSIS; RADIATION PNEUMONITIS; RADIATION RESPONSE; RADIOTHERAPY;

ANIMALS; BLOOD VESSELS; CELL HYPOXIA; COLLAGEN; ENDOTHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; ESTRADIOL; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG; MICE; PULMONARY FIBROSIS; RADIATION PNEUMONITIS; RADIOTHERAPY;

EID: 84942892712     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-14-3193     Document Type: Article

References (39)

1. Brush J, Lipnick SL, Phillips T, Sitko J, McDonald JT, McBride WH. Molecular mechanisms of late normal tissue injury. Semin Radiat Oncol 2007;17:121-30.
2. Fleckenstein K, Gauter-Fleckenstein B, Jackson IL, Rabbani Z, Anscher M, Vujaskovic Z. Using biological markers to predict risk of radiation injury. Semin Radiat Oncol 2007;17:89-98.
3. Sasse AD, Clark LG, Sasse EC, Clark OA. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a metaanalysis. Int J Radiat Oncol Biol Phys 2006;64:784-91.
4. Mehta V. Radiation pneumonitis and pulmonary fibrosis in non-small cell lung cancer: pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 2005;63:5-24.
5. Yarnold J, Brotons MC. Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol 2010;97:149-61.
6. Rodemann HP, Bamberg M. Cellular basis of radiation-induced fibrosis. Radiother Oncol 1995;35:83-90.
7. Fleckenstein K, Zgonjanin L, Chen L, Rabbani Z, Jackson IL, Thrasher B, et al. Temporal onset of hypoxia and oxidative stress after pulmonary irradiation. Int J Radiat Oncol Biol Phys 2007;68:196-204.
8. Saito A. EMT and EndMT: regulated in similar ways? J Biochem 2013;153:493-5.
9. Balli D, Ustiyan V, Zhang Y, Wang IC, Masino AJ, Ren X, et al. Foxm1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transition. EMBO J 2013;32:231-44.
10. Almeida C, Nagarajan D, Tian J, Leal SW, Wheeler K, Munley M, et al. The role of alveolar epithelium in radiation-induced lung injury. PLoS ONE 2013;8:e53628.
11. Potenta S, Zeisberg E, Kalluri R. The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer 2008;99:1375-9.
12. van Meeteren LA, ten Dijke P. Regulation of endothelial cell plasticity by TGF-beta. Cell Tissue Res 2012;347:177-86.
13. Hashimoto N, Phan SH, Imaizumi K, Matsuo M, Nakashima H, Kawabe T, et al. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2010;43:161-72.
14. Weintraub NL, Jones WK, Manka D. Understanding radiation-induced vascular disease. J Am Coll Cardiol 2010;55:1237-9.
15. Kim M, Choi SH, Jin YB, Lee HJ, Ji YH, Kim J, et al. The effect of oxidized low-density lipoprotein (ox-LDL) on radiation-induced endothelial-tomesenchymal transition. Int J Radiat Biol 2013;89:356-63.
16. Hong ZY, Lee HJ, Choi WH, Lee YJ, Eun SH, Lee JI, et al. A preclinical rodent model of acute radiation-induced lung injury after ablative focal irradiation reflecting clinical stereotactic body radiotherapy. Radiat Res 2014;182:83-91.
17. Lee YJ, Koch M, Karl D, Torres-Collado AX, Fernando NT, Rothrock C, et al. Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation ofmetalloproteinase ADAMTS1. Cancer Res 2010;70:948-56.
18. Lee YJ, Lee HJ, Choi SH, Jin YB, An HJ, Kang JH, et al. Soluble HSPB1 regulates VEGF-mediated angiogenesis through their direct interaction. Angiogenesis 2012;15:229-42.
19. Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A 2006;103:13180-5.
20. Grade NR, Peao MND, Sa CMd, P. Aguas A. Lung fibrosis induced by bleomycin: structural changes and overview of recent advances. Scanning Microsc 1998;12:487-94.
21. Lopez-Novoa JM, Nieto MA. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med 2009;1:303-14.
22. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 2008;19:2282-7.
23. Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 2013;498:492-6.
24. Zou H, Adachi M, Imai K, Hareyama M, Yoshioka K, Zhao S, et al. 2-methoxyestradiol, an endogenous mammalian metabolite, radiosensitizes colon carcinoma cells through c-Jun. NH2-terminal kinase activation. Clin Cancer Res 2006;12:6532-9.
25. Mueck AO, Seeger H. 2-Methoxyestradiol-biology and mechanism of action. Steroids 2010;75:625-31.
26. Fajardo LF. The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncol 2005;44:13-22.
27. Wang J, Zheng H, Hollenberg MD, Wijesuriya SJ, Ou X, Hauer-Jensen M. Up-regulation and activation of proteinase-activated receptor 2 in early and delayed radiation injury in the rat intestine: influence of biological activators of proteinase-activated receptor 2. Radiat Res 2003;160:524-35.
28. Molteni A, Moulder JE, Cohen EF, Ward WF, Fish BL, Taylor JM, et al. Control of radiation-induced pneumopathy and lung fibrosis by angiotensinconverting enzyme inhibitors and an angiotensin II type 1 receptor blocker. Int J Radiat Biol 2000;76:523-32.
29. Santana P, Pena LA, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M, et al. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 1996;86:189-99.
30. Vujaskovic Z, Anscher MS, Feng QF, Rabbani ZN, Amin K, Samulski TS, et al. Radiation-induced hypoxia may perpetuate late normal tissue injury. Int J Radiat Oncol Biol Phys 2001;50:851-5.
31. Basu RK, Hubchak S, Hayashida T, Runyan CE, Schumacker PT, Schnaper HW. Interdependence of HIF-1alpha and TGF-beta/Smad3 signaling in normoxic and hypoxic renal epithelial cell collagen expression. Am J Physiol Renal Physiol 2011;300:F898-905.
32. Sanders KA, Hoidal JR. The NOX on pulmonary hypertension. Circ Res 2007;101:224-6.
33. Ueno M, Maeno T, Nomura M, Aoyagi-Ikeda K, Matsui H, Hara K, et al. Hypoxia-inducible factor-1alpha mediates TGF-beta-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2011;300:L740-52.
34. Goggins BJ, Chaney C, Radford-Smith GL, Horvat JC, Keely S. Hypoxia and integrin-mediated epithelial restitution during mucosal inflammation. Front Immunol 2013;4:272.
35. Lakhani NJ, Sarkar MA, Venitz J, Figg WD. 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 2003;23:165-72.
36. Casarez EV, Dunlap-Brown ME, Conaway MR, Amorino GP. Radiosensitization and modulation of p44/42 mitogen-activated protein kinase by 2-Methoxyestradiol in prostate cancer models. Cancer Res 2007;67:8316-24.
37. Zou H, Zhao S, Zhang J, Lv G, Zhang X, Yu H, et al. Enhanced radiationinduced cytotoxic effect by 2-ME in glioma cells is mediated by induction of cell cycle arrest and DNAdamage via activation of ATM pathways. Brain Res 2007;1185:231-8.
38. Florczak U, Toulany M, Kehlbach R, Peter Rodemann H. 2-Methoxyestradiolinduced radiosensitization is independent of SOD but depends on inhibition of Akt and DNA-PKcs activities. Radiother Oncol 2009;92:334-8.
39. Salama S, Diaz-Arrastia C, Patel D, Botting S, Hatch S. 2-Methoxyestradiol, an endogenous estrogen metabolite, sensitizes radioresistant MCF-7/FIR breast cancer cells through multiple mechanisms. Int J Radiat Oncol Biol Phys 2011;80:231-9.